rs794726784
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001165963.4(SCN1A):c.4223G>A(p.Trp1408*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001165963.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN1A | ENST00000674923.1 | c.4223G>A | p.Trp1408* | stop_gained | Exon 24 of 29 | NM_001165963.4 | ENSP00000501589.1 | |||
SCN1A | ENST00000303395.9 | c.4223G>A | p.Trp1408* | stop_gained | Exon 23 of 28 | 5 | ENSP00000303540.4 | |||
SCN1A | ENST00000375405.7 | c.4190G>A | p.Trp1397* | stop_gained | Exon 21 of 26 | 5 | ENSP00000364554.3 | |||
SCN1A | ENST00000409050.1 | c.4139G>A | p.Trp1380* | stop_gained | Exon 21 of 26 | 5 | ENSP00000386312.1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Early infantile epileptic encephalopathy with suppression bursts Pathogenic:1
This sequence change creates a premature translational stop signal (p.Trp1408*) in the SCN1A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SCN1A are known to be pathogenic (PMID: 17347258, 18930999). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with severe myoclonic epilepsy in infancy (PMID: 12566275). ClinVar contains an entry for this variant (Variation ID: 189947). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
Generalized epilepsy with febrile seizures plus, type 2 Pathogenic:1
A heterozygous nonsense variation in exon 24 of the SCN1A gene (c.4223G>A) that results in a stop codon and premature truncation of the protein at codon 1408 (p.Trp1408Ter) was detected. The observed variant is not present in both the 1000 Genomes and gnomAD databases. The reference base is conserved across the species and in-silico prediction by Mutation taster is damaging. This variant has previously been reported for Dravet Syndrome by Xu X. et al., 2015. The stop gained p.Trp1408Ter in SCN1A (NM_001165963.4) has been reported to ClinVar as Pathogenic with a status of (1 stars) criteria provided, single submitter (Variation ID 189947 as of 2020-03-05). The gene SCN1A has a low rate of benign loss of function variants as indicated by a high LoF variants Z-Score of 7.90. The p.Trp1408Ter variant is a loss of function variant in the gene SCN1A, which is intolerant of Loss of Function variants, as indicated by the presence of existing pathogenic loss of function variant NP_001159435.1:p.Met1Ile and 346 others. There are 88 downstream pathogenic loss of function variants, with the furthest variant being 518 residues downstream of the variant p.Trp1408Ter. Based on the above evidence this variant has been classified as pathogenic according to the ACMG guidelines. -
Severe myoclonic epilepsy in infancy Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at